Clifton Cody L, Branham Ashley R, Hayes Harskin Hj, Moose Joseph S, Rhodes Laura A, Marciniak Macary Weck
J Am Pharm Assoc (2003). 2018 Jul-Aug;58(4S):S109-S113. doi: 10.1016/j.japh.2018.04.022.
To determine the financial impact of attributed patients enrolled in a medication adherence program at Community Pharmacy Enhanced Services Network (CPESN) pharmacies.
Five independently owned Moose Pharmacy locations in rural North Carolina, which are CPESN pharmacies.
Moose Pharmacy has a longstanding history of innovative change. Each Moose Pharmacy location provides enhanced pharmacy services, including adherence packaging, medication synchronization programs, immunizations, home visits, home delivery, comprehensive medication review, disease state management programs, point-of-care testing, and compounding.
Certain CPESN pharmacies, including Moose Pharmacy, were attributed complex Medicare or Medicaid patients having at least 1 chronic medication and at least 80% of medications filled at a CPESN pharmacy. Patients were included if they were attributed to a study location and enrolled in the Moose Medication Adherence Program (MooseMAP) for more than 12 months. Patients were excluded if they were younger than 18 years of age or had less than 12 months of prescription fill data. Reviewed data included patient demographics, chronic and acute medications, immunizations, MooseMAP type, number of chronic medication prescribers, chronic medication class, payer, and patient health risk indicators. Yearly profit for prescriptions filled was determined per patient. Independent-samples t test was used to assess data.
Yearly profit per prescription was $10.35 for combined chronic, acute, and immunization prescriptions, $10.57 for chronic prescriptions, $26.95 for acute prescriptions, and $27.69 for immunizations. Mean profit for strip packaging was $1561.82 per year compared with $1208.01 per year with bottles (P = 0.021). There was a positive correlation between profit and number of prescriptions filled per 12 months (r = 0.56; P < 0.001), number of medication classes (r = 0.27; P < 0.001), and higher-risk indicator scores (r = 0.21; P < 0.001).
Enrolling complex patients in a medication adherence program can benefit community pharmacies, particularly CPESN pharmacies, through chronic medication fills and yearly profit. Greater profit is generated when prescriptions are dispensed in strip packaging instead of bottles.
确定社区药房强化服务网络（CPESN）药房中参加药物依从性项目的归因患者所带来的财务影响。
北卡罗来纳州农村地区五家独立经营的穆斯药房，均为CPESN药房。
穆斯药房有着长期的创新变革历史。每家穆斯药房都提供强化药房服务，包括依从性包装、药物同步项目、免疫接种、家访、送货上门、全面药物审查、疾病状态管理项目、即时检验以及配制。
某些CPESN药房，包括穆斯药房，被归因于患有至少一种慢性药物且至少80%的药物在CPESN药房配药的复杂医疗保险或医疗补助患者。如果患者被归因于某个研究地点且参加穆斯药物依从性项目（MooseMAP）超过12个月，则纳入研究。如果患者年龄小于18岁或处方配药数据少于12个月，则排除。审查的数据包括患者人口统计学信息、慢性和急性药物、免疫接种、MooseMAP类型、慢性药物开方者数量、慢性药物类别、付款人以及患者健康风险指标。确定每位患者所配处方的年度利润。使用独立样本t检验评估数据。
慢性、急性和免疫接种处方合并后的每张处方年度利润为10.35美元，慢性处方为10.57美元，急性处方为26.95美元，免疫接种为27.69美元。条装包装的平均年度利润为每年1561.82美元，瓶装为每年1208.01美元（P = 0.021）。利润与每12个月所配处方数量（r = 0.56；P < 0.001）、药物类别数量（r = 0.27；P < 0.001）以及较高风险指标得分（r = 0.21；P < 0.001）之间存在正相关。
让复杂患者参加药物依从性项目可通过慢性药物配药和年度利润使社区药房，尤其是CPESN药房受益。处方以条装包装而非瓶装分发时利润更高。
